- Breaking News Software ensures translation accuracy
- Breaking News GM to honour all agreements
- Breaking News 5 Iranians nabbed with syabu-soaked clothes
- Breaking News Pei Tty-Eei Hui's chances look bleak
Tatung, SRI, Global Crossing, GM, Avaya, Terra Lycos leaders convene on the Future of IT at Worcester Polytechnic Institute Barcelona summit; WPI's corporate leaders roundtable explores the future impact of IT on academics and industry.
0 Comments | M2 Presswire, April, 2001
M2 PRESSWIRE-13 April 2001-Worcester Polytechnic Institute: Tatung, SRI, Global Crossing, GM, Avaya, Terra Lycos leaders convene on the Future of IT at Worcester Polytechnic Institute Barcelona summit; WPI's corporate leaders roundtable explores the future impact of IT on academics and industry (C)1994-2001 M2 COMMUNICATIONS LTD RDATE:12042001 WORCESTER, Mass.
- Worcester Polytechnic Institute (WPI) announces its first WPI Corporate Leaders Roundtable, Friday April 20, 2001 at the Hotel Majestic in Barcelona, Spain where global visionaries from corporate and academic sectors convene to explore the future impact of information technology (IT) on academics and industry. "This one-day event hosts presentations from leaders of Terra Lycos, Tatung,...
- Getting to the root of beautiful hair: shiny, silky hair begins with a healthy scalp - includes list of resources and a recipe for an herbal scalp tonic
- Industry Experts Launch Money Management Resources to Help People Overcome Debt and Learn Proper Money Management Practices
- Made from scratch: When Honda built a plant in Alabama it also built a workforce-using local workers who had no experience in making cars - Recruitment & Hiring
- Portfolio forecasting tools: what you need to know
- Banking technology, technological learning and competition: comparative case studies in Thai banking
- John Seely Brown Inducted Into 2004 Industry Hall of Fame
- SmartDisk's New VST Flash Media Reader(TM) Reads SmartMedia(TM), CompactFlash(TM) From A Single Desktop Unit
- FDA Approves REMICADE(R) for Ninth Indication: Psoriatic Arthritis